Method for discriminating between benign and malignant prostate tumors
    3.
    发明授权
    Method for discriminating between benign and malignant prostate tumors 有权
    区分良性和恶性前列腺肿瘤的方法

    公开(公告)号:US08213005B2

    公开(公告)日:2012-07-03

    申请号:US12654782

    申请日:2009-12-31

    IPC分类号: G01J3/30

    CPC分类号: G01N21/6486 G01N33/57434

    摘要: The method for discriminating between benign and malignant prostate tumors relates to analyzing samples of blood, urine and tissue by fluorescence spectroscopy in order to detect the presence of naturally occurring molecules in the fluids and tissue that serve as biomarkers indicative of cancer in the human body. The analysis can be carried out based on fluorescence emission spectra, fluorescence excitation spectra and synchronous (emission and excitation) spectra of bio-samples. The detection, diagnosis, and follow-up and also discrimination between malignant and benign prostate tumors may be made by comparison of ratios of fluorescence emissions and/or excitation intensities of tryptophan, tyrosine, elastin, collagen, bile pigments, NADH, flavins and various species of porphyrins.

    摘要翻译: 用于区分良性和恶性前列腺肿瘤的方法涉及通过荧光光谱分析血液,尿液和组织的样品,以便检测作为指示人体癌症的生物标志物的流体和组织中天然存在的分子的存在。 该分析可以基于荧光发射光谱,荧光激发光谱和生物样品的同步(发射和激发)光谱进行。 可以通过比较色氨酸,酪氨酸,弹性蛋白,胶原,胆汁颜料,NADH,黄素和各种颜色的荧光发射和/或激发强度的比例来进行恶性和良性前列腺肿瘤之间的检测,诊断和随访以及恶性和良性前列腺肿瘤的鉴别 卟啉物种

    Method for discriminating between benign and malignant prostate tumors
    4.
    发明申请
    Method for discriminating between benign and malignant prostate tumors 有权
    区分良性和恶性前列腺肿瘤的方法

    公开(公告)号:US20100173350A1

    公开(公告)日:2010-07-08

    申请号:US12654782

    申请日:2009-12-31

    IPC分类号: C12Q1/02

    CPC分类号: G01N21/6486 G01N33/57434

    摘要: The method for discriminating between benign and malignant prostate tumors relates to analyzing samples of blood, urine and tissue by fluorescence spectroscopy in order to detect the presence of naturally occurring molecules in the fluids and tissue that serve as biomarkers indicative of cancer in the human body. The analysis can be carried out based on fluorescence emission spectra, fluorescence excitation spectra and synchronous (emission and excitation) spectra of bio-samples. The detection, diagnosis, and follow-up and also discrimination between malignant and benign prostate tumors may be made by comparison of ratios of fluorescence emissions and/or excitation intensities of tryptophan, tyrosine, elastin, collagen, bile pigments, NADH, flavins and various species of porphyrins.

    摘要翻译: 用于区分良性和恶性前列腺肿瘤的方法涉及通过荧光光谱分析血液,尿液和组织的样品,以便检测作为指示人体癌症的生物标志物的流体和组织中天然存在的分子的存在。 该分析可以基于荧光发射光谱,荧光激发光谱和生物样品的同步(发射和激发)光谱进行。 可以通过比较色氨酸,酪氨酸,弹性蛋白,胶原,胆汁颜料,NADH,黄素和各种颜色的荧光发射和/或激发强度的比例来进行恶性和良性前列腺肿瘤之间的检测,诊断和随访以及恶性和良性前列腺肿瘤的鉴别 卟啉物种